Rimoy, G H <br/><br/>
The cardiovascular and central nervous system effects in the human of U-62066E. A selective opioid receptor agonist.  [electronic resource] 

 -  European journal of clinical pharmacology  1994 
 - 203-7 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article; Randomized Controlled Trial 
<br/><br/><label>ISSN: </label>0031-6970 
<br/><br/><label>Standard No.: </label>10.1007/BF00192549  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Blood Pressure--drug effects<br/>Central Nervous System Agents--pharmacology<br/>Cerebrovascular Circulation--drug effects<br/>Diuretics--administration & dosage<br/>Double-Blind Method<br/>Hemodynamics--drug effects<br/>Humans<br/>Hypnotics and Sedatives--pharmacology<br/>Injections, Intramuscular<br/>Injections, Intravenous<br/>Male<br/>Naloxone--pharmacology<br/>Norepinephrine--blood<br/>Psychometrics<br/>Pulse--drug effects<br/>Pyrrolidines--administration & dosage<br/>Receptors, Opioid, kappa--drug effects